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QUININE AND ITS S A L T S : THEIR SOLUBILITY 
AND ABSORBABILITY.
rH H E  administration of Quinine, although so old and well tried a remedy, 
_L is still beset with many difficulties and feelings of uncertainty on the 
part of the physician regarding the rapidity and certainty of action of a given 
dose of the alkaloid, by whichever channel that dose is administered. This is 
due mainly to our want of knowledge regarding the physical, chemical and, in 
particular, physiologico-chemical peculiarities of Quinine and its salts. The 
factors influencing the absurption of Quinine from the gastro-intestinal tract 
have been neglected ; and even the relative therapeutic or prophylactic value 
of the various methods of administration of Quinine is still unsettled.
By many it is assumed that Quinine is absorbed chiefly from the stomach, 
the intestines taking little or no part in the absorption. Malanin,1 in 1868, 
pointed out the insolubility of the compound formed by Quinine and bile acids, 
and took for granted that, when this alkaloid was administered by the mouth, as 
much of it as was not absorbed from the stomach became inert on coming in 
contact with bile in the intestines and was thus eliminated in the faeces. A 
similar action was ascribed to bile acids by Kerner.2 Lauder Brunton,3 on 
account of the precipitation from a mixture of Quinine and bile acids of this 
salt, which is sparingly soluble, except in an excess of bile, recommended clear­
ing out the liver by administering an emetic and a cholagotrue purgative before 
giving Quinine in the treatment of malaria. According to Sollmann,4 Quinine 
is fairly readily absorbed from the stomach : Giemsa and Scliaumann,6 however, 
have come to the conclusion that most of the Quinine given by the mouth is 
absorbed from the small intestine. Marshall6 states that most of the Quinine 
passes into the duodenum : and Dixon7 is of the opinion that after entering the 
duodenum Quinine is under ordinary circumstances absorbed rapidly ; but, if 
there is excess of alkali in the duodenum, Quinine is precipitated, forming with 
the bile acids insoluble salts which are passed unchanged in the foeces.
When there is so little agreement regarding the fate of Quinine in the 
gastro-intestinal tract, it is not surprising to find an explanation of the marked 
variations in the absorption of Quinine—so often encountered in clinical 
practice, sometimes even in the same individual and when using the same salt 
of this alkaloid—wanting, and the reason of the efficacy of a preparation like 
Warburg’s tincture still shrouded in mystery. Warburg’s tincture has been 
described as “  merely Quinine concealed in a farrago of inert substances.”  
To this description Maclean’s (Netley) reply8 was—“ I have never seen a single 
dose of Quinine given alone to the extent of 9^ grains sufficient to arrest an
exacerbation of remittent fever, much less prevent its recurrence ; while no­
thing is more common than to seethe same quantity of the alkaloid in Warburg’s 
tincture bring about such results.”  According to Sollmann4 the substances— 
aloes, rhubarb, camphor, gentian and aromatic substances which are combined 
with the alkaloid in Warburg’s tincture, “  probably aid in the absorption of the 
Quinine;”  and Cushny9 states that they promote Quinine absorption by acting 
on the stomach and that capsicum and piperine have a similar reputation as ad­
juvants in Quinine treatment. The view expressed in the National Dispensa­
tory40 is that Quinine absorption is hastened by the previous administration of 
purgatives, of which a combination of rhubarb and aloes acts best.
Regarding the relative value of the various methods of Quinine adminis­
tration, it will suffice in these introductory remarks to refer to only two—oral 
and hypodermic. Most authors of text-books of pharmacology and therapeutics 
assume that Quinine given by the hypodermic method is rapidly and effectively 
absorbed. Cushny9 recommends this mode of administration in cases of emer­
gency ; Sollmann4 states that by hypodermic injections, deep into the gluteal 
muscles, rapid action is secured ; Binz11 is of the opinion that absorption is 
thorough and quick. Many clinicians have expressed similar views. Recent 
experiments and clinical observations, however, have cast doubt upon the- 
orthodox belief that hypodermic injections of Quinine, as of other medicinal 
agents, mean more rapid and more concentrated action than is possible with ad­
ministration by the mouth. In Italy and Germany attempts have been made 
to solve this problem by laboratory methods. Kleine,13 on finding a smaller 
percentage of Quinine eliminated in the mine when the alkaloid was injected 
subcutaneously than when given by the mouth, came to the conclusion that 
absorption was less in the former instance and that the hypodermic method was 
therefore of less therapeutic value than the oral. Mariani13 made an intramus­
cular injection into the leg of a rabbit, with a solution of ‘201 gramme of the 
bi-hydrochloride of Quinine in one cubic centimetre of water, and from the 
muscle of the rabbit which was killed seventeen hours after the injection he 
recovered '1 gramme of anhydrous Quinine or 66’5 percent, of the amount 
injected. The results of Giemsa and Schaumann6 agree with those of Kleine :12 
they found that after oral administration the amount of Quinine eliminated in 
the urine was 38'5 per cent, of the dose administered and that after hypo­
dermic injection the amount eliminated was only 19-2 per cent. ;  but they 
regard this difference in the elimination of Quinine as due not to less absorption, 
but to a greater destruction of Quinine in the body when administered by hypo­
dermic injection than when given by the mouth. Krom the clinical aspect, the 
subject lias been investigated principally in India. Smytlie14 states that 
Quinine injected hypodermically is slowly absorbed and is eliminated in the
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urine for many weeks after administration ; and that 20 grains injected into 
the flanks will protect an individual from malaria for the following month at 
least. According to Megaw15 the temperature of patients suffering from 
malaria takes about twelve hours longer in coming to normal wheu treatment 
is by hypodermic injections (bi-liydrocliloride of Quinine in doses of 
10 grains) than when Quinine is given by the mouth, and consequently that 
absorption is slower from the subcutaneous connective tissue than from the 
mucous membrane of the stomach. Scott13 regards the hypodermic method 
(intramuscular) as of no special value in the treatment of acute cases of 
malarial fever, owing to slowness of absorption ; but he considers this method 
particularly useful as a preventive of frequently recurring attacks of ague.
The authors of the National Dispensatory10 acknowledge that the tendency 
of hypodermic injections to produce “  pain, inflammation, gangrene and even 
fatal tetanus more than counterbalances the advantages of facility of adminis­
tration and promptness of effect ”  and recommend that this method of adminis­
tration should be restricted to cases in which delay would be dangerous. The 
importance of determining whether or not this “ promptness of effect ”  is really 
obtained by the hypodermic method is obvious.
In an endeavour to throw some light on these debated points regarding the 
absorption of Quinine, this work has been undertaken. The alkaloid and its 
salts employed in the various experiments were obtained direct from Merck 
(Darmstadt) and therefore in unopened bottles.
Peculiarities of Quinine and its Salts.
Unfortunately, as the composition of many of the salts of Quinine varies 
with different manufacturers and as the details (temperature, etc.) regarding 
the conditions under which the results given by various analytical chemists 
have been obtained are not alway ? given, there is much uncertainty regarding 
the chemical properties, e.g., solubility, of some of these compounds. As 
those used in my investigations were obtained from Merck, I have, whenever 
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R e m a r k s .
Q. bi-hydrobromide 60-0 7 Faintly acid Recommended for hypoder­
mic injection.
Q. urea (carbamide) 70-0 1 ditto Recommended for hypoder­
mic injection.
Q. hydrochloride 81-7 37 Neutral
Q. sulphate 72-8 800 ditto
Q . lactate . 75'0 10 ditto Recommended for hypoder­
mic injection.
Q. hydrobromide. 76-6 45 ditto Recommended for hypoder­
mic injection.
Q. cacodylate 62-0 under 10 ditto
Q. phosphate 76-5 7S4 ditto Acicular crystals like the 
sulphate but harder and 
denser.
Q.. quinate 58-7 under 10 ditto Recommended for hypoder­
mic injection.
Q. acetate . 84-3 over 2,000 ditto
Q .  carbonate 80-2 o.rer 2,000 ditto
Q . tartrate 79-4 1,000 ditto
Q .  tannate 31-0 over 2,000 ditto Composition stated to be 
very variable.
Q. salicylate 68-8 2,30 ditto
Q. arsenate (basic) 68-0 over 2,000 ditto
Q .  arsenite 85-0 over 2,000 ditto
Q. valerianate 75-8 100 ditto
Q. benzoate 72-6 373 ditto
Q. formate (basic) 87-5 under 20 ditto Recommended for hypoder­
mic injection.
Q. alkaloid 85-7 1,670 Feebly basic
Practically all of these Quinine preparations require to be kept in well 
stoppered bottles, because of the readiness with which they part with water of 
crystallisation or take up moisture from the atmosphere. They also require
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to be protected from heat and light. At a low temperature, they keep- 
indefinitely: exposed to heat, they are liable to lose water of crystallisation and 
to become decomposed. Exposed to sunlight they acquire—whether in the 
solid form or in solution—a yellowish or brown colour. Fliicldger18 named this 
brown product “  quiniretin ”  and found it had the same composition as 
Quinine, but was destitute of its alkaline re-action; and, although soluble 
m acids, it could not neutralise them. Heat seems to accelerate this change 
in Quinine ; and boiling, whether for purposes of sterilization or of hastening 
solution, produces this change in some of these Quinine preparations in a 
few minutes. Quinine hydrochloride, besides being much more soluble than 
Quinine sulphate, contains a larger proportion of Quinine base and is much 
less irritating to mucous surfaces (stomach and rectum) : its solutions are less- 
likely to become mouldy, but are said10 to be much less stable than those of 
the sulphate.
Besides deterioration due to exposure to heat and light, solutions of 
Quinine salts are prone to become infected with moulds. In the literature 
on the subject solutions of Quinine sulphate alone are spoken of in this 
connection. According to Marshall,0 “  Quinine in general is fatal to moulds, 
but on standing exposed to the air solutions of Quinine sulphate quickly 
become infected with the common Penicillium, which grows rapidly.” 
Solutions of the various Quinine salts were kept in stoppered tube-bottles in 
the laboratory (Edinburgh University) for over three months, the bottles being 
opened and examined periodically. The sulphate solutions were the most liable 
to mould infection. The solution of Quinine sulphate with tartaric acid became 
infected very quickly and showed luxuriant mould growths under two Aveeks. 
Flavouring agents, such as syrupus aurantii, still further favour the growth of 
moulds, especially Penicillium glaucum. In these experiments the growth of 
moulds was not limited to the solution of Quinine sulphate and the genus of 
fungus was not confined to Penicillium. In luxuriance of mould growth, 
solutions of Quinine quinate and Quinine bi-hydrobromide ranked next to 
those of the sulphate. Growths Avere also present, but scanty, in solutions of 
bi-hydrochloride, bi-sulphate, urea bi-liydrochloride, lactate and arsenite. 
The genus Mucor, as judged from zygospore formation, was present in one 
or two instances, but the Perisporiacece predominated. Both genera, 
Aspergillus and Penicillium with their respective gonidiophores were in 
evidence, the former being almost as common as the latter. Perithecia, 
indicating the less frequent mode of reproduction, were observed in solutions 
of bi-hydrobromide, lactate and arsenite. It would appear therefore that 
Quinine is not so inimical to the higher members of fungi as to the lower 
yeast forms, Avhich are said8 to be as susceptible as bacteria to its action.
c 2
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Compatibility of Quinine Salts with Blood=Serum.
With the object of obtaining some information as to what actually 
happens when solutions of Quinine salts are injected subcutaneously or enter 
the blood stream, the behaviour of such solutions with ox blood-serum was 
investigated in vitro.
If '01 gramme of a Quinine salt, e.g., bi-liydrocliloride, bi-sulphate, bi­
hydrobromide, urea bi-hydrochloride, lactate, etc., is added direct in the form of 
a powder to one cubic centimetre of ox blood-serum in a test tube, a coarse curdy 
precipitate takes place. This precipitate, produced by 
adding one part of Quinine salt to 1G0 parts of ox 
blood-serum is not merely precipitated alkaloid, as it is 
insoluble in excess of serum.
As no further progress could be made by adding the 
dry Quinine salts to the serum, solutions of various 
strengths of the Quinine salts were prepared and the 
effects produced by adding one cubic centimetre of these 
solutions to one cubic centimetre of ox blood serum ob­
served. The following table gives the results, one cubic 
centimetre of Quinine salt solution being in each instance 
mixed with one cubic centimetre of blood-serum. The upper line opposite 
each salt indicates the results got immediately on mixing Quinine salt solution 
with serum ; the lower line the effects produced after standing 24 hours:—
Table II.
Chief Quinine salts 
used for hypodermic 
injection.
D i l u t i o n  o f  Q u i n i n e  s a l t  s o l u t i o n .
1 -2 . | 1 -1 0 .
■
1-50. 1 -1 0 0 . 1 -2 0 0 .
Q. bi-hydrochloride.
Gray syrupy- 
liquid. Precipitate Precipitate Paint haze No change.
Gelatinous mass Gelatinous mass Deposit Paint deposit . Haze.
Q. bi-sulphate .
Precipitate H aze Paint haze No change.





Qui n i n e
s a l t  in 
powder 





Chief Quinine salts 
used for hypodermic 
injection.
D i l u t i o n " o f  Q u i n i n e  s a l t  s o l u t i o n .
1-2. 1-10. 1-50. 1-100. 1-200.
Q. bi-hydrobromide
Precipitate Precipitate Faint haze No change.




T recipitate Precipitate Faint haze No change.
Gelatinous mass Curdy mass . Deposit Faint deposit . Haze.
Q. hydrochloride .
Precipitate Faint haze Xo change.
Deposit Faint deposit . Haze.
Q. lactate .
Precipitate Precipitate Faint haze No change.
Deposit Deposit Faint deposit . Haze.
Q. hydrobromide . „
Precipitate Faint haze No change.
Deposit Faint deposit . Haze.
Q. quinate
Precipitate Precipitate Faint haze No change.
Deposit Deposit No deposit Faint haze.
Q. cacodylate ' .
Precipitate Precipitate Faint haze No change.
Deposit • Deposit No deposit Faint haze.
Q. formate
Precipitate Faint haze No change.
Deposit Faint deposit . Haze.
Solutions of Quinine hydro chloride prepared with the addition of 
antipyrine, urethane or sodium chloride, respectively, as recommended for
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hypodermic or intravenous use, were tested in the same way, hut they showed 
no greater compatibility or miscibility with ox blood-serum than did simple 
solutions of Quinine hydrochloride itself.
Using dilutions of Quinine salts of 1 in 20, the results were the same 
as under 1 in 50 in above table, only more pronounced, with the exception of 
Quinine bi-liydrobromide which even in this dilution of 1 in 20 produced a 
thick semi-solid mass of jelly consistence. This behaviour of the bi-liydro- 
bromide is the more remarkable as it contains a comparatively low percentage 
of anhydrous Quinine base. The bi-hydrobromide therefore appears to be 
the least compatible with ox blood-serum.
The above re-actions were carried out at laboratory temperature (12°C.). 
The effect of incubating the mixture of Quinine salt solution and serum at 
37°C. was tested in a feAV instances and the result was an acceleration of the 
changes that were seen to occur at laboratary tenrperature.
Gfiemsa and Schaumann'5 having observed the behaviour in vitro of 
saturated solutions of some of these salts of Quinine with (1) pig blood-serum 
and (2) human blood-serum have recorded very similar results.
A  series of tubes was next prepared to compare the relative amount of 
precipitate and deposit formed by adding solutions of the strength of 1 in 80 
of each of these Quinine salts to ox blood-serum. Two tubes showed no 
deposit, but only a flocculent precipitate in suspension—quinate and cacody- 
late: of the tubes presenting a deposit, the bi-sulphate showed the least 
deposit and the least opacity of the supernatant fluid, On referring to the 
table giving the percentage of anhydrous Quinine base in Quinine salts it 
will be noticed that the quinate, cacodylate and bi-salpliate are exactly those 
salts which contain the smallest percentage of Quinine base. A second 
series of tubes were therefore prepared using solutions of the same salts 
having a strength of 1 of Quinine base in 80. Judging from the amount 
of deposit and the degree of transparency of the supernatant fluid, the acid 
salts of Quinine seemed the most compatible with the serum ; but the re­
actions of the mixtures containing the acid salts were found to be very faintly 
acid. Of the neutral salts of Quinine there seemed to be slightly greater 
miscibility with serum on the part of the qninate and cacodylate.
As the salts used for these re-actions have been specially chosen as 
those generally recommended for subcutaneous injection, the results tabulated 
strongly suggest an utter unsuitability, especially in the dilutions usual]y 
employed, of Quinine salts for hypodermic injection. The three salts most 
frequently used, bi-hydrochloride, urea bi-hydrochloride and bi-hydrobromide, 
and in the dilutions most frequently employed produce in a few minutes at 
body temperature when mixed with ox blood-serum a gelatinous mass.
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It was considered desirable to determine whether the Quinine in these 
mixtures of blood-serum and Quinine salt solutions was present (1) in solution 
in the supernatant fluid, (2) in the suspended precipitate, or (3) in the 
deposit.
The tube containing the mixture of blooi-serum and Quinine bi-sulphate 
1 in 80 was taken and its contents filtered. The clear filtrate gave an 
intense emerald green colour on the addition of chlorine water and ammonia, 
so that the filtrate contained Quinine in solution. The deposit was examined 
next. It was thoroughly washed with water till the washings no longer 
gave any colour re-action with these reagents, and then treated with Aveak 
sulphuric acid. The deposit Avas not dissolved, but some of the supernatant 
fluid was placed in a clean test-tube and the reagents, chlorine water and 
ammonia, added. An intense deep-blue colour resulted. This blue solution was 
divided between two test-tubes, one of Avhich was heated and the other kept at 
laboratory temperature. The solution in the tube that was heated turned green 
in a couple of minutes ; the solution in the tube left at laboratory temperature 
turned green in three days. These results suggest that Quinine AAras present in 
the deposit but in an altered form, and probably as an oxidised product.
A  quantitative estimation of the Quinine in solution and in suspension 
A v a s  carried out as follows :—
A  mixture of serum and Quinine hydrochloride solution Avas specially pre­
pared by dissolving '1 gramme Quinine hydrochloride in tAvo cubic centimetres 
of boiling water which on cooling was added to tAA-o cubic centimetres of ox 
blood-serum. After half-an-liour this mixture Avas filtered through cotton a v o o I 
Avith the aid of a water-suction pump. The filtrate was made strongly alkaline 
AA'ith liquor potassae, when a heavy white precipitate of Quinine alkaloid took 
place. This milky suspension was then extracted three times with ethyl setlier 
and the sethereal extracts filtered. The aether Avas evaporated from the filtrate 
and the residue dissolved in alcohol. The alcoholic solution Avas then filtered 
and the filter-paper washed Avith a little alcohol, the filtrate and washings 
being received into a weighed porcelain capsule. The alcohol was evaporated 
on a water-bath and the residue dried at 120° C., when the capsule and residue 
were Aveighed. The calculation was as follows :—
Capsule +  dried extract , =  12’4St gm.
Capsule . . . . , =  12‘440 ,,
dried extract 0-044< gm.
The dried extract is, of course, anhydrous Quinine base. Now, Quinine 
hydrochloride contains 82 per cent, anhydrous base ; therefore O'014 gramme
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anhydrous base corresponds with 0'0536 gramme Quinine hydrochloride. It 
follows therefore that 0'0536 gramme Quinine hydrochloride was in solution in 
the mixture.
hiext a similar mixture— ‘1 gramme Quinine hydrochloride dissolved in two 
cubic centimetres of boiling water which after cooling was added to two cubic 
centimetres of ox blood-serum—was prepared and allowed to stand till the deposit 
had settled. The supernatant fluid was pipetted off and (in order to lose as
little as possible) the residue was filtered through fine meshed cloth, a thick
yellow creamy deposit being left behind on the cloth. The fluid pipetted off 
and that filtered through the cloth were mixed and made strongly alkaline with 
liquor potassm. 'the resulting suspension was thrice setherised; the aether
extracts filtered ; the aether evaporated ; the residue dissolved in alcohol; the 
solution filtered and the filtrate and washings evaporated in a weighed capsule 
on a water-bath ; and the residue, dried at 120° C., weighed—in the manner 
already described, The results were as follows :—
Capsule +  dried extract „ . =  12-0435 gm.
Capsule . =  1T995 ,,
.\ dried extract . . . . . =  0-04-85 gm.
Now, 0'0485 gramme anhydrous Quinine base corresponds with 0'0591 
gramme Quinine hydrochloride; so that the amount of Quinine hydrochloride in 
solution and in suspension in the mixture amounts to 0'0591 gramme.
It is evident therefore that in such a mixture as that prepared above, out 
of ‘1 gramme Quinine hydrochloride contained in it, there was (1) in solution, 
•0536 gramme, (2) in the suspended precipitate, ( ‘0591— '0536) gramme, i.e.> 
•0055 gramme and (3) in the deposit, (-1—’0591) gramme, i.e., '0109 gramme of 
Quinine hydrochloride respectively. In other words slightly over half the 
Quinine was in solution and slightly under half was contained in the deposit— 
probably transformed (oxidised), combined Avith proteids and therapeutically 
useless. The importance of this obseiwation in connection with the hypodermic 
administration of Quinine salts is obvious. In this particular instance the 
strength of the Quinine salt solution that had been added to the blood-serum 
was about 1 in 20, Avhich is much more dilute than the solutions generally 
used for hypodermic injection. It will he evident, on referring to the table 
giving miscibility of Quinine salt solutions with ox blood-serum, that the 
greater the dilution of the Quinine salt solution the less is the deposit that 
forms, and therefore presumably, the greater is the proportion of Quinine in 
solution until finally in extreme dilution no deposit takes place and all the 
Quinine is in solution.
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The action of Quinine salt solutions on blood-serum reminds one strongly 
of that of alcohol, which in greater concentration than 33 per cent, is quite 
incompatible with blood-serum but in greater dilution perfectly miscible.
Solubility of Quinine Alkaloid in Ox Blood=Serum.
With 25 cubic centimetres of ox blood-serum, fresh and centrifuged, '1 
gramme crystalline Quinine alkaloid was shaken up in a flask and incubated 
at 37° C. for two hours, during which time the flask was frequently shaken. 
After these two hours, the flask and its contents were allowed to cool at 
laboratory temperature (12° 0.), and then the contents were filtered through 
cotton wool with the aid of a water-suction pump. The amount of alkaloid in 
solution in the clear filtrate was determined as follows :—
The filtrate was made distinctly alkaline with liquor potassse and the 
resulting suspension thrice shaken up with ethyl aether. The aether extracts 
were then filtered and the aether evaporated. The residue was dissolved in 60 
per cent, alcohol and this solution filtered into a weighed porcelain capsule. 
The filtrate and washings Avere evaporated on a water-bath, avoiding boiling, 
and the residue dried at 120° C. and weighed. The following figures were 
obtained:—
Capsule +  chied residue= 12'474 gm.
Capsule =  12'440 „
.*. dried residue= 0'034 gm. (anhydrous Quinine base).
Now, crystalline Quinine alkaloid contains 85'7 per cent, anhydrous Qui­
nine base; therefore, 0'034 gramme anhydrous Quinine base corresponds with 
*0397 gramme crystalline Quinine alkaloid. Thus *0397 gramme crystalline 
Quinine alkaloid was dissolved in 25 cubic centimetres of ox blood-serum,—i.e., 
practically 4 parts in 2,500 parts of serum or 1 in 625. Crystalline Quinine 
alkaloid is therefore nearly three times as soluble in ox blood-serum as in water..
Solubility of Quinine Alkaloid in Ox Bile.
Malanin1 in 1868 demonstrated the insolubility of the compounds formed 
by the union of Quinine and bile acids and assumed from this that the intestines 
took little or no part in the absorption of Quinine. A  similar action was 
attributed to bile acids by Kerner.2 Lauder Brunton,3 while acknowledging 
the sparingly soluble character of the precipitate obtained by adding Quinine 
to bile acids, refers to its solubility in an excess of bile. The opinion expressed 
by Dixon7 is that after entering the duodenum Quinine is under ordinary 
circumstances absorbed rapidly; but if there is excess of alkali in the 
duodenum Quinine is precipitated, forming Avitli the bile acids insoluble salts 
which are passed unchanged in the foeces. It is, however, pointed out by
D
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Marshall6 tliat the precipitate of Quinine glycocholate which is obtained by- 
adding a solution of Quinine to bile, although very insoluble, is easily decom­
posed by carbonic acid and alkaline carbonates, and under ordinary circum­
stances probably plays little part in the absorption of Quinine.
The solubility of crystalline Quinine alkaloid in fresh ox bile was deter­
mined by me in the following manner
“With 15 cubic centimetres of fresh ox bile (the re-action of which tested 
with red litmus paper, was faintly alkaline) '2 gramme crystalline 
Quinine alkaloid was shaken up in a flask. To ensure small division 
of the Quinine the alkaloid was first triturated in a test-tube with a 
little of the bile by means of a glass rod. The flask after being well 
shaken was incubated at 37°C. for three hours, and shaken frequently 
during this period. The flask and its contents were then cooled at 
laboratory temperature (12°C.). The contents of the flask were fil­
tered through cotton wool with the aid of a water-suction pump, the 
residue on the cotton wool being washed with a small amount of cold 
water and the washings added to the filtrate. The clear filtrate was 
made distinctly alkaline with liquor potassae. The resulting suspen­
sion was shaken up three times with ethyl aether. The aether extract 
was filtered and the aether evaporated from the filtrate in a stream of 
hot air (80°C.). The residue was dissolved in 96 per cent, alcohol and 
this solution filtered. The filtrate and washings were evaporated to 
dryness on a water-batli. The residue was then dissolved in weak 
sulphuric acid and the resulting solution filtered, the filter being 
washed with a little of the sulphuric acid. The filtrate and washings 
were made distinctly alkaline with liquor potassse and the resulting 
emulsion thrice shaken up with aether. The aether extract was fil­
tered into a weighed porcelain capsule and the aether evaporated in a 
stream of hot air (80°C). The extract was then further dried at 120°C. 
and weighed—with the following results :—
Capsule +  dried extract=12,065 gm.
Capsule =  l l -996 „
*   .
dried extract= 0'069 gm. (anhydrous Quinine base).
As crystalline Quinine alkaloid contains 85-7 per cent, anhydrous Quinine 
base, '069 gramme anhydrous Quinine base corresponds with -082 gramme 
crystalline Quinine ; alkaloid. Therefore, 15 cubic centimetres of ox bile 
dissolved ’082 gramme crystalline Quinine alkaloid; i.e., 15,000 cubic centi­
metres of ox bile, can dissolve 82 grammes of crystalline Quinine alkaloid ; i.e.,
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183 cubic centimetres of ox bile can dissolve one gramme crystalline Quinine 
alkaloid. Crystalline Quinine alkaloid is therefore about nine times as soluble 
in ox bile as in water. This result differs considerably from that of Giemsa and 
Schaumann5 who, using amorphous Quinine alkaloid instead of the crystalline 
form used by me, give the amazing solubility of 1 in 8 3 ;—i.e., Quinine alkaloid 
(amorphous) is twenty times as soluble in ox bile as in water. The amorphous 
form would certainly dissolve more quickly than the crystalline, so the solubility 
may be under-estimated in my experiments. It is worthy of note also, in this 
connection, that the Quinine alkaloid that is precipitated on Quinine salts- 
coming in contact with alkali in the duodenum must be of the amorphous 
variety.
Absorption of Quinine.
Hitherto, experimenters have taken the amount of Quinine eliminated in 
the urine as a measure of the amount that has been absorbed and entered the 
circulation. It is, therefore, necessary to examine the reliability of this gauge.
Until the beginning of the last decade the views held regarding the elimi­
nation of Quinine appear to have been quite erroneous ; there was a lack of 
harmony in the results obtained by different investigators not only regarding the 
proportion of Quinine eliminated but also regarding the chemical characters of 
the Quinine or its derivatives that were eliminated. According to Kernel’ 2 
and Merkel10 most of the Quinine was eliminated unchanged in the urine, the 
remaining part being excreted in the form of transformed products. Personne,20 
however, affirmed that only about half the Quinine administered is eliminated 
unchanged in the urine and that the other half is destroyed in the body and not 
excreted as transformed products. Schmitz31 aud also Giemsa and Schaumann® 
have confirmed Personnels observation that only unchanged Quinine is elimi­
nated in the urine ; and they maintain that there is no Quinine derivative with 
alkaloidal characters present in detectable amount in the mdne after Quinine 
administration.
Practically speaking, only traces of Quinine are eliminated by channels 
other than the kidneys. Mariani13 was able to detect traces in the milk of 
nursing mothers and in sweat, in the latter only after the secretion had been 
concentrated by evaporation. Prom the bitter taste experienced for a long 
time after taking Quinine in wafers, Giemsa and Schaumann5 are of opinion 
that probably a very little is excreted in saliva. In the feces, under ordinary 
circumstances, very little is eliminated : after administration by the mouth, 
Kernel’3 could find traces only ; Merkel19 could find no Quinine ; Kleine,22 ’3 per 
cent, at most; Flamini,23 using the insoluble tannate of Quinine, 8—15 per cent., 
Schmitz21 traces on ly; and Giemsa and Schaumann,5 even after the adminis­
tration of the insoluble alkaloid itself, traces only—amounts so small that they
d  1
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■could not be weighed. So far therefore as elimination by other channels is con­
cerned, Quinine excretion in the urine is quite a feasible gauge of absorption.
Regarding the rate and amount of elimination of Quinine in the urine 
there is commendable harmony in the results of recent investigators. After 
medium doses f e.g. one gramme) of Quinine administered by the mouth while 
fasting, the average amount eliminated in the first 24 hours has been given by 
Kleine22 as 2T9 per cent., by Mariani13 as 24’7 per cent., by Flamini23 as 24'6 
per cent., by Schmitz21 as 19'5 per cent., and by Giemsa and Schaumann5 as 
25-8 per cent., and under the same conditions the average total elimination (i.e., 
the amount eliminated during the two or three days Quinine excretion lasted) 
according to the same authorities is about 40 per cent. It would appear there­
fore that under these circumstances about 60 per cent, of Quinine is destroyed 
in the body. That the amount of Quinine eliminated in the urine should 
vary, as a rule, between fairly narrow limits when the mode of administration 
and other conditions are similar is what one would expect. But even, under 
such conditions, Giemsa and Schaumann,5 who regard the amount of Quinine 
elimination in the urine as the best practical measure of the amount absorbed, 
acknowledge that in particular individuals there are considerable variations 
from the normal, and that even in the same individual there might be striking 
variations on different days even when examination of the fæces showed that 
absorption was similar on all the days. Further, even granting that under 
similar conditions as regards mode of administration, state of gastro-intestinal 
tract, etc., the amount of Quinine eliminated in the urine is fairly constant, it 
cannot be assumed that under altered conditions the relative amounts of Quinine 
eliminated in the urine will be proportional to the corresponding amounts of 
Quinine absorbed. To show that such an assumption would be wrong it is only 
necessary to compare the average amounts of Quinine eliminated in the urine 
after intravenous administration on the one hand and intramuscular or oral on 
the other. Mariani13 gives the following averages :—•
Table III.
Intravenous injection. Intramuscular injection. Oral administration (fasting).
1st day 20-54% 18-47% 24-70%
2nd day 6-33% 9-60% ?
3rd day . 1-07% 4-91% ?
4th day 2-45% ?
T otal 27-94% 35-43% 40-88%
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These figures sliow that after intravenous injection less Quinine (totals) 
is eliminated in the urine than after either intramuscular injection or oral 
administration. As with intravenous injection there can he no doubt about 
the Quinine entering the circulation, it is evident that Quinine elimination 
in the urine cannot be directly proportional to the amount of Quinine that has 
entered the blood. Further, on referring to the amounts of Quinine eliminated 
during the first day, it is quite obvious that there is no direct relationship 
between the amount of Quinine that has entered the circulation and the 
amount that has been excreted : if it be said that elimination varies directly 
with absorption, then more Quinine entered the blood after oral administration 
than after intravenous; if it be said that elimination varies inversely with 
absorption, then more Quinine entered the blood after intramuscular injection 
than after intravenous.
In reality, the amount of Quinine absorbed must be equal to the amount 
of Quinine eliminated in the urine plus the amount that has undergone cleavage 
in the body. The determination of the amount of Quinine eliminated in the 
urine cannot possibly give us any idea of the amount absorbed unless we are 
able to determine at the same time the amount that has undergone cleavage 
or to satisfy ourselves that the amount that has undergone cleavage is constant. 
Under different conditions of Quinine administration, each of these three 
factors varies ; and as there is no means of estimating the amount of Quinine 
that has undergone cleavage in the body the amount of Quinine eliminated in 
the urine is quite fallacious as a universal gauge of the amount of Quinine that 
has entered the circulation.
There is, however, another method, namely, that of determining the mini­
mum-lethal dose—which hitherto seems to have escaped notice—which is cap­
able of giving us a rough estimate of the amount of absorption, especially when 
comparing different methods of administration of Quinine. The toxicity or 
lethality of a substance must be proportional to the rapidity and thoroughness of 
its absoption, no matter by what channel or under what conditions the substance 
is administered. And, as in calculating the minimum-lethal dose, death must 
occur within twenty-four hours, rapidity may be taken as a constant, so 
lethality varies directly with thoroughness of absorption.
Oral Administration.
As already noted, many assume without any definite proof that Quinine 
is absorbed chiefly from the stomach. In their opinion Quinine, in whatever 
form administered, is converted to some extent into the soluble hydrochlorides
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in the stomach, and almost all the Quinine that passes into the duodenum is. 
immediately and permanently rendered inert by the bile acids and alkaline 
fluids, the alkaloid precipitated by the alkaline juices being very insoluble 
in water.
For determining the seat of absorption, the following points haye to be 
considered— (1) the time interval between administration and the first appear- 
tance of Quinine in the urine; (2) the period of maximal limination in the 
urine ; (3) the period during which subjective symptoms, e.g. tinnitus, are 
at their worst; and (4) the period of manifestation of symptoms in cases of 
poisoning (suicidal in man and experimental in animals).
As regards the stomach, it must be conceded that Quinine is very soluble in 
gastric juice ; but gastric juice is likely to be present in a stomach only dur­
ing digestion, when little of it can be spared for Quinine. In fact, recent in­
vestigators are in harmony regarding the retardation of Quinine absorption 
when administered with or soon after a meal. According to Mariani,13 the maxi­
mal elimination of Quinine, given while food is in the stomach, takes place 
between the sixth and twelfth hours after administration ; but, given when no 
food is in the stomach, between the third and sixth hours. As food does not, under 
normal circumstances, remain in the stomach more than five hours, it follows 
that most of the Quinine given with food is absorbed from the small intestine. 
Subjective symptoms moreover, just like the maximal elimination of Quinine 
in the urine, are at their height between the third and sixth hours when 
Quinine is given while fasting and betwreen the sixth and tvrelfth horns when 
given with a meal. That some absorption may take place from the stomach 
cannot be denied, for the following reasons, but such absorption is probably 
very insignificant. Kerner2 found traces of Quinine in the urine 15 minutes- 
after administering Quinine hydrochloride by the mouth ; Lewin21 has confirmed 
this, giving the time as 13 to 17 minutes; Giemsa and Schaumann5 found 
traces in the urine 25 to 30 minutes after giving the sparingly soluble Quinine 
alkaloid by the mouth.
In the small intestine, the alkaline secretions of the liver, pancreas and 
intestine itself in all probability precipitate the alkaloid. Preference has 
previously been made to the insolubility of Quinine glycocholate, and Lauder 
Brunton’s3 advice to clear out the liver by administering an emetic and a 
cholagogue purgative before giving Quinine. That such measures as Lauder 
Brunton recommends are useful in enhancing the therapeutic value of Quinine 
in obstinate cases of malarial fever is well recognised by experienced physicians. 
This beneficial result, however, is probably obtained, not by preventing bile 
from coming in contact with the Quinine, but by actually favouring contact of 
as much bile as possible with the Quinine. It has been shown above that, accord-
»
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ing to my calculation, Quinine alkaloid is about nine times as soluble in ox bile 
as in water, and according to that of Griemsa and Schaumann5 about twenty 
times. Further, the glycooholate of Quinine is soluble in excess of bile 
and is easily decomposed by carbon dioxide and alkaline carbonates. Lastly, as 
pointed out by Kerner,2 Quinine salts are much more soluble in aerated than in 
ordinary water, and carbon dioxide is possibly of importance in the process of 
absorption of Quinine from the intestine.
From the large intestine probably little Quinine is absorbed. The results 
of recent workers show a great falling off in the amount of Quinine eliminated 
subsequent to a period of twelve hours after administration. Peristalsis, more­
over, being less active and the contents of the bowel having acquired greater 
consistence, there is less contact between alkaloid and mucous membrane. 
Lastly, the elimination of Quinine after administration in the form of an 
enema is relatively small. Kleine12 after administering two grammes of 
Quinine hydrochloride in 100 cubic centimetres of water as an enema found 
only 17‘55 per cent, eliminated in the urine in the first 24 hours, as compared 
with 25 per cent, in the same period when the same salt in the same dose was 
administered by the mouth.
Kobert23 relates a case of suicide on the part of a schoolmistress who 
. swallowed four drachms of Quinine followed by the juice of two lemons. 
Unfortunately, the interval of time between her last meal and her taking the 
Quinine is not mentioned ; but the periods at which the different toxic 
symptoms appeared are interesting from two points of view. In the first 
place, the minimum lethal dose for man being about four drachms,25 the 
correspondence between the periods at which the various symptoms in this 
case of suicide and in the minimum-lethal dose experiments in guinea-pigs 
is striking : secondly, if in the case of suicide the stomach was empty at the time 
of swallowing the Quinine, then absorption was chiefly from the small intestine. 
The mimimum-lethal dose experiments were carried out for testing the relative 
-absorption after oral and hypodermic administration and not for determining 
the seat of absorption of Quinine. For the latter purpose such experiments 
are of limited value until it is known how long food usually remains in the 
guinea-pig’s stomach. Bub this much can confidently be said—that the 
Quinine could nob have reached heyond the small intestine when toxic symp­
toms were fully developed. Two series of feeding experiments were carried out 
with guinea-pigs, (1) after fasting 24 hours, and (2) immediately after food. 
The guinea-pigs were fed by passing the Quinine solution (Quinine bi-hy- 
- drochloride 1 in 30) through a No. 3 gum male catheter into the stomach. 
As gravity was insufficient to pass the solution into the stomach, a 
'•Becord syringe was used instead of a reservoir to hold the solution and
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force it through the catheter into the stomach. The sequence of events is 
given in the accompanying table alongside that in the case of suicide—
Table IV.
G u i n e a - p i g s , m i n i m u m -l e t h a l  o e  s u b -
Time after 
ingestion.
LETHAL DOSE OE QUININE BI-H YDEOCH LOB- 
IDE 1-30 BY MOUTH. Case of suicide. Quinine 
4 drachms +  2 lemons
After meal. Pasting (24 tours).
swallowed.





•  a a Twitckings
4 „ Twitckings Unconsciousness and convulsions.
4-4 „ . . . Convulsions Convulsions.
6 „ . . . Convulsions Convulsions and death.
64 » Convulsions Deatk if letkal dose ; 
signs of recovery if 
sub-letkal.
There is therefore reason to believe that, under ordinary circumstances, 
most of the Quinine administered by the mouth is absorbed from the small 
intestine ; a small amount possibly from the stomach, especially if adminis­
tered while fasting and in the form of a salt easily soluble in water ; and also 
a relatively small amount from the large intestine. As already mentioned, the 
absorption of Quinine is normally very complete, very little being passed with 
the faeces after medium doses.
F a c t o r s  i n e x u e n c i n g  a b s o r p t i o n  p r o m  t h e  g a s t r o - i n t e s t i n a l  t r a c t .
1. Food contents o f  the gastro-intestinal tract.— There seems no doubt 
that, if Quinine is administered with or soon after a meal, absorption and elimi­
nation are retarded (Kleine,22 Mariani,13 Griemsa and Schaumann5). When ad-4 
ministered with a meal, Giemsa and Schaumann found traces of Quinine in 
the urine only after two hours ; when given fasting, they could detect traces in 
20 to 30 minutes. Regarding total Quinine elimination see under (4) below.
2. Affections o f  the gastro-intestinal tract.—The frequency with which 
purgatives (not necessarily cholagogue) are administered before Quinine is 
evidence that experience has taught physicians that a sluggish or loaded bowel 
is not favourable to Quinine absorption. Marshall6 reports that in diseased 
conditions of the heart or kidney absorption is delayed : this no doubt is due
1.9
to a catarrlial condition or chronic venous congestion of the gastro-intestinal 
tract and liver.
3. Affections of the liver.—The probable adjuvant action of bile in Quinine 
absorption has already been discussed. Carrive28 has reported a case of hepatic 
insufficiency in malaria (diagnosed by blood examination), and supposed to be 
due to malaria, in which there was complete cessation of bile secretion and 
diminished liver dulness. Under such circumstances Quinine by the mouth 
would probably have very little therapeutic effect.
à. The solubility o f  the Quinine salt employed.— Mariani,13 who has made a 
thorough investigation of the effects on elimination of Quinine of the solubility 
of the salt administered and of the food contents of the gastro-intestinal tract, 
came to the conclusions that the total Quinine elimination is greater after 
administering insoluble than after administering easily soluble salts ; and that the 
total Quinine elimination is also greater when Quinine is administered with a 
meal than when fasting. G-iemsaand Schaumann,5 using Quinine hydrochloride 
and Quinine alkaloid, likeAvise conclude from the urine analyses that the less 
soluble preparations of Quinine are at least as energetically absorbed from the 
gastro-intestinal tract as are Quinine salts easily soluble in water.
As it seemed reasonable to doubt the validity of inferring more energetic 
absorption from the fact of the total Quinine elimination being greater, I 
determined the minimum-lethal dose of Quinine bi-hydrocliloride for guinea- 
pigs (1) after fasting 2-1 hours and (2) immediately after food.
Table V.
M i n i m u m - L e t h a l  D o s e  o e  Q u i n i n e  b i - h y d r o c h l o r i d e  e o r  G u i n e a - p i g s
B Y  O B A L  A D M IN IS T B A T IO N .









animal weight in 
grammes.
Eesnlt.
550 0T 65 ' 0-3 Recovery. Distinct effects.
620 0-217 0-35 Recovery. Distinct effects.
510 0-204 0-4 Recovery. Very severe effects.
610 0-244 0-4 Recovery. Very severe effects.
600 0-240 0-4 Died in 6 —7\  hrs.
470 0-2115 0-45 Died in 8 hrs..
520 0-234 0-45 Died in 6 hrs.
500 0-2-5 0-5 Died in 21 hjn,
E
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animal weight in 
grammes.
Kesult.
630 0'252 0-4 Recovery. Slight effects.
630 0-2835 0-45 Recovery. Slight effects.
660 0-295 0-45 Died in 11 hrs.
500 0-25 0-5 Died in 6J hrs.
500 0-25 0-5 Died in 6— 7 hrs.
The minimum-lethal close per kilogramme when Quinine is given with food 
is larger (about ‘5 gramme) than when given after a fast of 24 hours (about '45 
gramme). ¥ e  must conclude, therefore, that, so far at least as guinea-pigs are 
concerned, absorption is more energetic when the animal is fasting. The same 
most probably holds for man, the reason for the greater total elimination of 
Quinine in the urine when Quinine is administered with food being a 
slower and more gradual absorption of Quinine, with a consequent smaller 
amount of cleavage of the alkaloid. When Quinine is administered during a 
fast, there is probably an early abrupt and energetic absorption with pro­
portionate cleavage of the alkaloid. Iiapid and energetic absorption is most 
likely best obtained, therefore, by giving a soluble Quinine salt during a fast; 
a slow, gradual but persistent action by giving insoluble salts of Quinine with 
meals.
Soluble salts of Quinine, if given in capsules, a,re apt to form temporarily 
local concentrated solutions in the stomach and cause gastric discomfort and 
even serious injury to that organ. It is also worth noting that, where the 
ordinary salts of Quinine cause gastric irritation, the difficulty may be overcome 
by administering one of the insoluble salts, e.g., the tannate, which is 
practically insoluble till it reaches the intestine.
5. Carbon dioxide ( COz).— It has been shown by Kernel’2 that Quinine and 
its salts* are much more soluble in aerated than in ordinary water. When 
Quinine sulphate is dissolved in aerated water, no immediate precipitate is 
produced by adding an equivalent amount of sodium carbonate; and, no 
precipitate is produced by adding a concentrated Quinine solution to a dilute 
¡solution of sodium bicarbonate in aerated water. These results suggested to
* N ote.— W ater saturated with carbonic acid dissolves Quinine sulphate freely.
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Kerner that carbonic acid probably plays an important part in dissolving 
Quinine, both in the process of absorption and in the blood. The results of bis 
experiments also seem to show that aerated water, swallowed with Quinine or 
injected with Quinine as an enema, facilitates the absorption of the alkaloid. 
Further support is given to Kerner’s idea of the importance of carbonic acid as 
a solvent by the following experiment, reported by Wood.27 The amount of 
pure Quinine that 1,000 parts of blood defibrinated and deprived of its gases at 
36° 0. can dissolve is only '398 part, which gives a solubility of about 1 in 25,00. 
It has been shown above that Quinine alkaloid is soluble 1 part in 625 of' 
ordinary ox blood-serum.
6. Single large closes o f Quinine or the same amount in divided closes in the 
course o f the day.— Giemsa and Scbaumann3 have shown that, with the daily 
administration of one gramme of Quinine in one dose, 23‘8 per cent, was 
eliminated daily in the urine; with the daily administration of "2 gramme 
every two hours till five doses were given, the corresponding figure was 27'8 
per cent. From this they conclude that Quinine in divided doses is of greater 
therapeutic value than in single large doses, as in the former case less Quinine 
is destroyed in the body. They therefore support the treatment of malaria by 
fractional doses of Quinine, as recommended by Nocht28 and TJfer.29
With the single large dose the absorption of Quinine for a certain period 
of time must have been much greater than could occur at any time after 
administration in divided doses. With the abrupt accentuated absorption from 
the single large dose, it is reasonable to expect greater cleavage of Quinine by 
the protective forces of the body, hence the diminished elimination in the 
urine. Further, there is no reason to suppose that the Quinine which under­
goes cleavage is of no therapeutic value before cleavage has occurred; so the 
inference of Giemsa and Schaumann that greater elimination in the urine 
connoted greater therapeutic value is unwarranted. With single large doses 
Quinine absorption is accentuated for certain intervals of time; with the small 
frequently repeated doses absorption is never accentuated, but continues evenly 
at a moderate average. The only way to settle the relative therapeutic value 
of these two methods of administration is by actual clinical results. 
Nocht seems to have obtained good results by giving four grains of Quinine 
every two hours, day and night (if awake), but the great majority of physicians 
have by experience come to rely more on 15 grains three times daily: in the 
former instance about 48 grains are given daily, in the latter 45 grains. A c ­
cording to Wood,27 large doses at intervals have been found in practice better 
than small amounts frequently, and this conclusion is supported by observations 
made by Councilman30 that large doses entirely destroy the parasite whereas 
fractional doses do not.
e  2
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Quinine in tlie form of "Warburg’s tincture lias often been found efficient 
wben Quinine administered in tlie ordinary way has been unavailing. It will 
be interesting, therefore, to examine its constitution in an attempt to explain the 
secret of its efficacy. It is composed of Quinine snlpbate with aloes, rhubarb, 
gentian and aromatics digested with proof spirits. It is recommended that 
the bowels be first evacuated by any convenient purge.31 This preliminary 
purgation removes any obstacle to the progress of the Quinine along the 
intestinal canal, prevents dilution of the Quinine by the previous contents of 
the intestine, permits more ready contact between the Quinine and the 
mucous membrane of the intestine, and increases the general tone of the whole 
intestinal tract. It will be observed also that the tincture contains two 
cholagogne purgatives—aloes and rhubarb. These can help absorption in two 
ways, (l).by  increasing the flow of bile, and (21 by increasing peristalsis which 
favours contact of Quinine with the intestinal mucous membrane. To prevent 
any griping, due to these two purgatives, aromatics are present in abundance. 
There is still another possible action of these two purgatives which lias to be 
guarded against besides griping. It is not desirable that the Quinine should 
pass too rapidly along the intestinal tract. For this purpose prepared chalk 
and a little opium are generally included in the composition of the tincture 
these tend to diminish the intestinal secretions, and so impede the progress of the 
Quinine in the intestine. Two other recommendations31 generally accompany 
the tincture: (1) it is to he taken alone without dilution, and (2) all drinks are 
withheld after its administration : these precautions, besides preventing dilu­
tion, which would diminish contact of Quinine with intestinal mucous 
membrane, probably help to retard the progress of the Quinine along the 
intestinal tract. These latter effects are also favoured or aided indirectly by a 
further recommendation—that the patient should be well covered after the 
administration of the tincture and diaphoresis encouraged.
Subcutaneous (including Intramuscular) Administration.
Until quite recently no one ever douhted or questioned the alleged advan­
tages of the hypodermic injection of Quinine,—rapidity and accentuation of 
action as in the case of other medicinal substances that are commonly adminis­
tered in this way. And, even now, all authoritative books on pharmacology 
and therapeutics, while noting its drawbacks and dangers, recommend the 
hypodermic administration of Quinine in malignant types of malaria, Binz 11 
.states that the satisfactory results obtained by this method of treatment show 
that the Quinine is thoroughly absorbed. Some.medical officers would even go 
the length of giving Quinine hypodermically as routine practice in preference 
to oral administration. According to the National Dispensatory,10 however, the
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tendency to produce “ pain, inflammation, gangrene and even fatal tetanus”  
more than counterbalances the advantages of facility of administration and 
promptness o f effect, and the use of this method of administration should he 
restricted to cases in which .delay may he dangerous.
The behaviour of those Quinine salts that are used for hypodermic injec­
tion, in different strengths of solution, when mixed Avitli ox blood-serum, lias 
already been described. It should he noted also that solutions of Quinine 
hydrochloride prepared with the addition of antipyrine, urethane and sodium 
chloride, respectively, as recommended by some for hypodermic and intravenous 
use, were tested in the same way and showed no greater miscibility with ox 
blood-serum than did simple solutions of Quinine hydrochloride itself. The 
ordinary Quinine hypodermic injection, as recommended by Squire,33 is not 
more dilute than 1 in 6 ; the strength of Burrough’s and Wellcome’s Quinine 
bi-hydrochloride Vaporóles is 1 in 5 ; and the strength of extemporaneous 
Quinine injections generally borders on 1 in 1^. Solutions of Quinine of such 
strengths must of necessity result in a coagulum and precipitation of much 
•of the Quinine at the seat of injection. It has already been shown that the 
addition of a 1 in 20 solution of Quinine hydrochloride to an equal volume 
of ox blood-serum throws about half the Quinine, temporarily at least, out of 
: solution. An examination of Table II  strongly suggests that the more con­
centrated the solution of Quinine salt, the more alkaloid will be precipitated in 
the mixture with serum; and the more dilute the solution of Quinine salt, 
the less alkaloid will be thrown out of solution. One would expect therefore 
from these serum experiments that much of the Quinine contained in the 
ordinary Quinine hypodermic injection would be thrown out of solution at 
the point of injection, but that, if the Quinine injection is sufficiently dilute 
(1 in 150), little or no Quinine would be deposited in the tissues.
It will be remembered that the substance separated by adding dilute 
; sulphuric acid to the coagulum (formed by adding Quinine hydrochloride 1 in 
20 to serum), after the latter had been washed free from all traces of Quinine, 
gave a blue colour when treated with chlorine water and ammonia, and that 
this blue colour changed to green rapidly on heating, but after a few days if 
left at laboratory temperature. This substance is probably an oxidation product 
of Quinine, and the ease with which it can be re-converted into Quinine sug­
gests that, although much Quinine is thrown out of solution at the seat of in­
jection apparently as a transformed product in combination with albumen 
(compare with Bossbach’s33 investigations), Quinine may be gradually liberated 
from the coagulum for two or three days after injection. Beference will 
again be made to this coagulum in connection with the occurrence of tetanus 
after Quinine injections.
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Giemsa and Scbaumann5 state that a solution of one part of Quinine urea 
bi-hydrochloride in ten of water is particularly suited for subcutaneous use. 
Table II shows that in this dilution Quinine urea forms a curdy mass only when 
mixed with serum, and that, in the same dilution, quinine bi-hydrochloride 
produces a gelatinous mass. The latter salt, however, contains considerably 
more Quinine base than the former ; and, when solutions of both salts each 
containing 1 in 80 of Quinine base were tested with serum, no difference in 
the behaviour of the two salts could be detected.
From the small amount of Quinine eliminated in the urine after hypo­
dermic injections and from his findings at the point of injection Kleine22 came 
to the conclusion that Quinine was precipitated largely at the seat of injec­
tion, and that Quinine was very slowly absorbed from this dépôt by the lymph 
stream. He was of opinion that absorption lasted for weeks, and that such a 
prolonged action would be useful in the treatment and prophylaxis of malaria. 
Mariani,13 however, showed that this Quinine depot at the point of injection 
did not persist beyond five or six days, and so rejected the idea that subcutaneous, 
administration was particularly useful for the prophylaxis of malaria. That 
Quinine was precipitated at the point of injection he settled by experiment. 
He injected Quinine bi-hydrocliloride (about 1 in 5) intramuscularly in the leg 
of a rabbit and 17 hours thereafter killed the rabbit and recovered from the 
muscles 66'5 per cent, of the amount injected. Kleine,12 on finding that elimi­
nation in the urine was so small in amount and that elimination did not 
continue so long as he had formerly supposed, concluded that the subcutaneous 
administration of Quinine was of less therapeutic value than the oral.
There is very little harmony in the results of experimenters who have 
investigated the proportion of Quinine eliminated in the urine after hypoder­
mic injection. There is one point, however, on which they are all in agree­
ment, namely, that the proportion of Quinine eliminated, when administered
subcutaneously, is much less than when given by the mouth. The following 
gives the proportions eliminated in the first twenty-four hours after adminis­
tration (1) by mouth and ( 2) subcutaneously :—
By month (fasting) =  2B91%  iK leine)22 
Subcutaneously 12T 3%  ' '*
Do' = TiTïi (Mariani)-13
n  _  19-50% 21
~ TTV% (Schmitz)-
25-8 0/
D °- = i2 T 6 ”f  bising dilute solution) (Giemsaand Schaummn).3
25
Kleine22 gave ‘5 gramme Quinine bi-hydrochloride subcutaneously to each 
■of two patients and found the amount eliminated in the first 24 hours in one 
case was 11*37 per cent, and in the other 9*70 per cent. To another patient he 
gave *5 gramme Quinine hydrochloride, and the amount eliminated in the first 
24 hours was 15*32 per cent. The greater excretion in the last case probably 
accompanied a greater absorption due to the greater dilution in which the 
hydrochloride was probably given owing to its less solubility. Mariani13 tested 
the effect of concentration of the Quinine injection on the elimination. In 
the one case he injected one gramme of Quinine bi-liydrocliloride in ten cubic 
•centimetres of water and in the other case the same salt and dose in two cubic 
centimetres of water ; in the former, 13*7 per cent, was eliminated in the first 
24 hours ; in the latter, 15*791 : in the former, elimination was at its height 
between the sixth and twelfth hours after injection; in the latter, between 
the ninth and eighteeth hours after injection. It is worthy of note that 
differences in dilution of 1 in 2 and 1 in 10 had no great influence on the 
amount of Quinine excreted and probably absorbed. This agrees with the 
results obtained by me in the minimum-letlial dose experiments. Giemsa and 
Schaumann,5 however, using Quinine urea have obtained very different 
results. They carried out two sets of experiments : in one set they adminis­
tered one gramme of Quinine urea in ten cubic centimetres of water to each 
patient daily, and in the other set one gramme of Quinine urea in one cubic 
centimetre of water daily, with the following tabulated results :—
Table VI.
A.— Daily subcutaneous injection o f 1 gm. 
Quinine urea in 10 c.c. o f  water.
B .— Daily subcutaneous injection o f  1 
Quinine urea in 1 c.c. o f  water.
gm.











1st day . 21-0 24rl 19'8 1st day • • 10-3 12-1
2nd day 26-2 24-9 22-0 2nd day • • 16-3 15-1
3rd day ... 26-9 ... 3rd day 18-2 19-3
A v e r a g e  . 23-6 25-3 20-9 A v e r a g e ■ • 14-9 15-5
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; They report that, in the case of those who received the Quinine in a dilu­
tion of 1 in 10, elimination ended within 48 hours after the last injection ; and 
that in the other case elimination was pronounced for four or five days after the- 
last injection. It is difficult to explain the differences in elimination shown in 
Tables A  and B. Judging from the in vitro experiments, there is no reason 
why Quinine urea should he better absorbed than Quinine bi-hydrochloride. 
It would appear, moreover, that Quinine urea has not fulfilled the hopes- 
entertained of i t ; for Giemsa34 has recently recommended the combination of 
Quinine hydrochloride with urethane for hypodermic injection. Urethane 
and antipyrine increase the solubility of Quinine hydrochloride, new chemical 
products being formed from which, it is thought, Quinine is liberated in the- 
body. Gaglio35 recommended the urethane solution as being neutral, non-irri­
tating and stable: after its hypodermic injection he recovered from 30 to- 
50 per cent, in the urine and concluded that it was rapidly and completely 
absorbed. Schmitz,21 however, has been unable to confirm these results ;, 
giving the urethane solution hypodermically to a patient daily for seven days, 
he found the daily amount eliminated was only 16‘1 per cent, on an average. 
Recently Giemsa34 seems to have given up the use of Quinine-urea in favour of 
this urethane solution of Quinine hydrochloride, the advantages he puts forward 
for the latter being: that it will stand boiling for an hour and is not de­
composed by heat like Quinine urea while being sterilized, that it is well 
absorbed, that it has a similar re-action to that of the tissue fluids and that its 
intramuscular injection is almost painless. In the antipyrine solution of 
Quinine hydrochloride, quinopyrin is formed, which according to Santesson 
is less toxic than Quinine, but according to Stofella is useless.36 Regarding 
these solutions resulting in the formation of new compounds Marshall38 states 
that they should he looked upon with suspicion. Moreover, it should he noted 
that their miscibility with ox blood-serum is no greater than that of solutions- 
of simple Quinine hydrochloride itself. Solubility in water is merely of advan­
tage during the process of injecting; it is solubility or miscibility in serum that 
favours absorption.
Clinically, one striking point about the hypodermic administration of 
Quinine is the sudden great increase recently in dosage by this method. A  few 
years ago the hypodermic dose of Quinine was usually given as from four to six 
grains ; at present the dose is generally from ten to fifteen grains—the same 
as when given by the mouth. This indicates that absorption after oral adminis­
tration is at least as complete as after hypodermic. In comparing the two- 
methods of administration there remains therefore only the question of prompt­
ness of action. Smythe’s14 experience is that after hypodermic injection Quinine 
is slowly absorbed and that its elimination takes weeks; that 20 grains injected.
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in the flanks give protection from malaria for at least a month. According to 
Megaw,15 the temperature of malarial patients takes about twelve hours longer in 
coming to normal when treated by the hypodermic method than when Quinine 
is given by the mouth ; from this it is assumed absorption is slower from the 
subcutaneous tissues than from the mucous membrane of the gastro-intestinal 
tract. Scott10 has come to the conclusion that the hypodermic (intramuscular) 
mode of administration of Quinine has no special value in the treatment of 
acute cases of malarial fever owing to slowness of absorption. The results 
obtained by Cohen37 are interesting from two points of view : they show the 
conclusions arrived at by an advocate of Quinine injections, and they were 
obtained by the use of Quinine urea which was so strongly recommended by 
Giemsa and Schaumann. Cohen states that 15 grains of Quinine urea, if 
injected during or within four hours after a paroxysm of malarial fever, were 
readily absorbed and procured freedom from fever for a period of from six to 
thirteen days : he, however, admits that Quinine by the mouth is “  equally 
efficacious His statements that the Quinine urea was readily absorbed from 
the point of injection and that freedom from fever was obtained for from six to- 
thirteen days are hardly consistent.
The evidence, so far, casting doubt upon the alleged therapeutic value of; 
the subcutaneous administration of Quinine can be summarised as follows :—
I . — A b s o r p t i o n .
(1) Experimental.—The behaviour of Quinine solutions when mixed with 
ox blood-serum suggest the possibility of very dilute solutions of Quinine (1—150) 
but the unlikelihood of concentrated solutions, such as ordinary Quinine hypo­
dermic injections, being readily absorbed : it suggests the probability that most 
of the Quinine in hypodermic injections is thrown out of solution at the point 
of injection, is combined with albumen in an oxidised but unstable form and is 
gradually liberated from this combination.
Mariani’s13 experiment, in which he recovered from rabbit’s muscle 66'5 
per cent, of the dose of Quinine (Quinine bi-hydrochloride 1 in 5) injected 17 
hours before the rabbit was killed, is positive proof that Quinine was deposited 
at the point of injection, and that most of the Quinine was still lying at the 
point of injection 17 hours after the injection was made.
The experiments on Quinine elimination in the urine give very little 
information regarding Quinine absorption. One point which seems to he 
definitely settled is that the amount of Quinine eliminated in the urine after 
hypodermic injection is invariably less than that after oral administration. By
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the advocates of hypodermic injection, the diminution in Quinine excretion is 
attributed to greater cleavage of Quinine in the body after absorption from the 
seat of injection. The results of different experimenters vary considerably,— as 
one would expect seeing that the degree of dilution of the Quinine solution both 
before and after injection (and consequently the amount of Quinine thrown 
out of solution at the point of injection) is subject to considerable variation.
(2) Clinical.—There is a considerable amount of evidence that absorption is 
no better after hypodermic than after oral administration; and that, however 
useful hypodermic injections may be for prophylaxis, hypodermic medication is 
not so good in the treatment of malaria as oral. Reference !has already been 
made to the recent great increase in the dose of Quinine when given 
hypodermically and to the observations of Smythe and Scott.
I I .—P r o m p t n e s s  o p  e p p e c t .
(1) Experimental.—-Mariani13 after injecting one gramme of Quinine 
bi-hydrochloride dissolved in ten cubic centimetres of water found that the 
maximum elimination of Quinine in the urine occurred between the sixth and 
twelfth hours after injection ; and that, after injecting one gramme of the same 
salt dissolved in two cubic centimetres of water, the maximum elimination 
occurred between the ninth and eighteenth hours. It has already been 
stated that after oral administration during fasting the maximum elimina­
tion of Quinine occurs between the third and sixth horns; and during or soon 
after meals, between the sixth and twelfth hours. It is evident therefore, if per­
missible to draw conclusions regarding absorption from Quinine elimination in 
the urine, that maximum absorption and consequently maximum therapeutic 
effect is obtained later after hypodermic injection (in dilutions at least up to 
1 in 10 which include all Quinine hypodermic injections as ordinarily given)
Than after oral administration.
(2) Clinical.—The results obtained by Megaw15 point to absorption being 
slower from the subcutaneous tissues than from the gastro-intestinal mucous 
membrane.
Mini mum-Lethal Dose experiments on Guinea-pigs with Quinine 
bi=hydrochloride by oral and subcutaneous administration.
Reid Hunt33 has shown that temperature may have a great influence on the 
results of such experiments on small animals. Experimenting by subcutaneous 
injections on mice, be found that doses otherwise non-letlial were fatal on cold 
days. All the following experiments were carried out at a temperature within 




A . — M i n i m u m - L e t h a l  L o s e  b y  O r a l  A d m i n i s t r a t i o n .  











550 0'165 0-3 Recovery. Distinct effects.
620 0-217 0-35 Recovery. Distinct effects.
510 0-20-1 0 4 Recovery. Very severe effects.
610 0-244 0-4 Recovery. Very severe effects.
600 0-240 0-4 Died in 6-—7§ hours.
470 0-2115 0-45 Died in 8 liours.
520 0-234 0-45 Died in 6 hours.
500 0-25 0-5 Died in 21 hours.












630 0-252 0-4 Recovery. Slight effects.
630 0-2835 0-45 Recovery. Slight effects.
660 0-295 0-45 Died in 11 hours.
500 0-25 0-5 Died in 6r hours.
500 0-25 0-5 Died in 6— 7 hours.
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C .— M i n i m u m - L e t h a l  L o s e  b y  S u b c u t a n e o u s  I n j e c t i o n .












730 0-073 0-1 Recovery. Very slight effects.
590 0-118 0-2 Recovery. Marked effects.
710 0-1775 0-25 Recovery. Very severe effects.
570 0-1596 0-28 Recovery. Very severe effects.
490 0-147 0-3 Died in 7| hours.
620 0-186 0-3 Died in 7 hours.
L . — M i n i m u m - L e t h a l  L o s e  b y  S u b c u t a n e o u s  I n j e c t i o n .











475 0-1425 0-3 Recovery. * Marked effects.
610 0-244 0*4 Recovery. Slight effects.
550 0-275 0"5 Recovery. Distinct effects.
510 0-306 0-6 Died in 23J hours.
660 0*396 0-6 Died f  in 4 hours.
650 0-455 0-7 Died in 19J hours.
580 0-522 0 9 Died in 9— 11 hours.
* This animal was a weakling and was accidentally chosen for experiment.
t  At the post-mortem examination, much exudate was found in the loose tissue at the point of injection.
E.—M i n i m u m - L e t h a l  D o s e  b y  S u b c u t a n e o u s  I n j e c t i o n .












570 0-171 0-3 Recovery. Slight effects.
590 0-236 0-4 Recovery. Slight effects.
580 0-29 0-5 Recovery. Distinct effects,
560 0-246 0-6 Recovery. Marked effects.
410 0-336 0-6 Died in 8§ hours.
The minimum-lethal doses, therefore, sufficiently accurate for comparative 
purposes are as follows :—
By oral administration (fasting) . . =  ••15 gm. per kilo.
„  „  (after food) . . =  '5 „  „
By subcutaneous injection 1 — 150 . . =  -3 ,, „
>> )> 1 — 2 . , =  '6 ,, ,,
„  „ 1  — 8 . = over-6  „  „
The higher minimum-lethal dose shown by these results for injections of 
1 in 8 dilution, as compared with 1 in 2, is probably explained by my having 
■carried out the experiments with 1 in 8 dilution last of all ; for, having observed 
that diffusion of the injected fluid by massage or movement on the part of the 
animal had some effect—although slight—on the results, the animals that 
received injections of 1 in 8 dilution were kept quiet in the hands for five or 
ten minutes after injection. The lethality, and therefore the absorbability, of 
Quinine are in the following order, beginning with the most lethal mode of 
•administration :—
(1) Subcutaneous injection in extreme dilution (1—150) ;
(2) Oral administration during fasting ;
(3) Oral administration with or soon after food ;
(4) Subcutaneous injection in the strengths generally used for hypoder­
mic injection (1 in 2 and 1 in 8).
And as that mode of administration which is most lethal to the animal 
would almost certainly be the most lethal to any parasite in the animal’s blood 
or tissues, it follows that the therapeutic value of the different modes of 
administration is also in the order given for lethality. As will be evident later, 
the subcutaneous injection of Quinine in extreme dilution (or rather, as it 
should be called, subcutaneous infusion) is not feasible for clinical reasons ; so 
for all practical purposes, if it is permissible to generalise from those experi­
ments on guinea-pigs, Quinine by the mouth is of greater therapeutic value 
in  respect of amount o f  absorption than subcutaneous Quinine injections.
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With the object of getting some idea as to the relative promptness o f  action 
attained by the different methods of administration, the time of appearance of 
the various toxic symptoms in each experiment was carefully noted,— with the 
following results.
Table VIIL 
M inim um -Lethal Dose Experiments on Guinea=pigs.









Dose =■ about 
•5 gm. per kilo.
1-150.
Bose =  about 
'3 gm. per kilo.
1-2.




'6 gm. per kilo.
f  hour. ... ... Unsteadiness ...
1 » ... ... Convulsions ...
£ hours.
2 i  „ Unsteadiness
... Inability to 
stand.
...
3 „ ... Unsteadiness ... ...
H „ 
















61 » ... Convulsions • • * ... ...
8 „ ... • • • ... Convulsions Convulsions
Recovery un­
der 24 hours 
if dose sub- 
lethal.
Recovery un­
der 24 hours 
if dose sub- 
lethal.
Recovery under 
24 hours if dose 
sub-lethal.
Recovery took 
at least 30 
hours if dose 
sub-lethal.
From this table it is evident that, as regards promptness of effect, the 
various modes of administration stand in exactly the same order as that given 
for lethality or absorbability. The time at which the various toxic symptoms 
appeared in the case of suicide (already described) by swallowing four drachms 
of Quinine, which is about the minimum lethal dose for man, corresponded so
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closely with that given in this table that probably all the results tabulated 
here hold good approximately for man. Other reasons that justify the applica­
tion of this table to man are the following“ :—■
The maximum elimination of Quinine in man’s urine after Quinine by 
the mouth during fasting occurs between the third and sixth hours 
(Mariani13).
The maximum elimination of Quinine in man’s urine after Quinine by the 
mouth after food occurs between the sixth and twelfth hours (Mariani13).
The maximum elimination of Quinine in man’s urine after a subcutane­
ous injection of one gramme of Quinine bi-hydrochloride (1) dissolved in 
ten cubic centimetres of water occurs between the sixth and twelfth 
hours, and (2) dissolved in two cubic centimetres of water occurs 
between the ninth and eighteenth hours (Mariani13).
These results obtained by Mariani correspond in a very striking manner 
with the appearance of convulsions in the guinea-pigs in the minimum-lethal 
dose experiments.
The results tabulated above may therefore be taken as practically conclu­
sive ; and they show that the oral administration of Quinine affords more 
prompt action of the alkaloid than does the subcutaneous.
The following curves give a graphic representation of the absorption of 
Quinine after administration in the various methods already referred to, the 
dose of Quinine being taken to be the same in each case:—
Curves of Quinine Absorption after various Methods 
of Administration.
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Subcutaneous Quinine infusions being debarred, Quinine by the mouth 
with or soon after meals suggests itself as particularly suited for the treatment 
of malaria in which sporulation is irregular, and also for prophylaxis. Quinine 
by the mouth while fasting would be serviceable two or three hours before a 
paroxysm where sporulation recurred regularly.
In the curve representing absorption when Quinine is given with meals 
(absorption in such a case according to Mariani13 is at its height between the 
sixth and twelfth hours) it will be noticed that absorption from the fifth to the 
thirteenth hour, i.e., for eight hours, is higher than it ever reaches when an or­
dinary Quinine hypodermic injection containing the same close of Quinine is 
given. It follows therefore that Quinine given with (or soon after) meals three 
times a day every eight hours, will keep the amount of Quinine in the body at 
a higher level than one could ever hope to do by giving similar doses of 
Quinine hypodermically in the usual concentrated solutions.
Local and Post=mortem Changes found in the Quinea=pigs 
used for the Minimum-Lethal Dose Experiments.
A few minutes after injection into the subcutaneous connective tissue, 
the skin overlying the injection become discoloured and yellow, and soon an 
area of skin corresponding to the size of the injection had undergone necrosis 
—killed directly by the action of the Quinine. The epidermis and hairs over 
this area could be peeled off by rubbing it with the blunt edge of a knife. If 
the animal survived, a red raw ulcer resulted ; no pus was seen, possibly owing 
to the tissues at the base and edge being saturated with Quinine which checks 
diapedesis of leucocytes. In one case, where the injection had been large, 
necrosis had extended on the deeper surface through all the abdominal muscles 
right down to the peritoneum. The layer of muscle underneath the injection 
was invariably necrosed and looked like washed gray leather. Not infre­
quently the yellow necrosed mass became surrounded by an inflamed indurated 
area prior to the eschar being cast off. Even Quinine solutions so dilute as 
1 in 150 had a severe necrotic action on all tissues with which they came in 
contact : the superficial muscular layer of the abdominal wall was invariably 
necrosed, as was also the skin, the result being generally, if the animal sur­
vived, a huge ulcer occupying the greater part of the surface of the abdominal 
wall. This extensive ulceration and necrosis preclude Quinine infusions from 
clinical use.
I f any blood vessels happened to be included in the eschar, they appeared 
like black threads and could easily be picked out in the pale necrosed tissues : 
the blood they contained was invariably clotted. In several instances, includ­
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ing cases both of oval and subcutaneous administration, liaemorrhagic erosions 
were found in the stomach,—-particularly in guinea-pigs that had survived some 
twenty hours or so after injection. One guinea-pig which had received 
Quinine by the mouth was found to have had an extensive haemorrhage in the 
lower part of the large intestine. These haemorrhages are most probably due 
to engorged capillaries giving way. In typical cases, the ventricles of the heart 
were found empty and pink in colour (therefore not contracted or in rigor) ; 
both auricles were enormously distended with dark venous blood ; and all large 
veins were engorged with blood.
Hypodermic Injections in General and those of Quinine in 
Particular.
A substance, to be suited for hypodermic injection, should satisfy the 
following requirements:—
(1) It should be capable of being easily sterilized, e.g., stand boiling.
(2) Its solution ready for injection should be in small bulk, i.e., the sub­
stance should be very active pharmacologically and be very soluble 
in water, saline or other menstruum.
(3) It should be capable of rapid and thorough absorption, i.e., its solu­
tion in the concentration in which it is injected should be compa­
tible with serum and lymph.
(4) It should be non-in jurkrus to the tissues locally.
(5) It should be non-irritating.
Now, examining Quinine according to this standard, it is evident that one 
only of these five requirements is satisfied. Quinine can be got into sufficiently 
small bulk for injection, but in this concentration it cannot he absorbed rapid­
ly or thoroughly, and it is irritating and very injurious to the tissues at the 
point of injection. Regarding sterilization, none of the salts of Quinine 
stands heating well. Quinine is therefore fundamentally unsuited for 
hypodermic use.
Further, Quinine injections, although devoid of any therapeutic advantage 
over administration by the mouth, are not infrequently attended by serious 
complications, mutilation and dangers.
(1) Necrosis.—From the rapidity with which this occurred in the guinea- 
pig experiments and from the rapid yellow discolouration of the skin, it 
is practically certain that this necrosis is due to the direct action of the 
Quinine, which even in a dilution of 1 in 150 kills outright all tissues 
which by diffusion it reaches. Thrombosis could not possibly produce necrosis 
so rapidly.
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(2) Thrombosis.— I f by accident some solution is injected into a blood vessel, 
rapid thrombosis and possibly embolism results. Thrombosis, however, occurs in 
vessels which have not been directly injured by the hypodermic needle; for, all 
vessels in the necrosed area contain clotted blood. If, therefore, the injection is 
made near a large blood vessel, thrombosis in that vessel may cause ischaemic 
paralysis.
(3) Paralysis.— Besides ischaemic paralysis from thrombosis of a large 
artery, paralysis may also occur from direct destruction of a nerve near which 
the Quinine may have been injected. Quinine has no specific affinity for any 
special tissue, such as strychnine and nerve cells: if in sufficient concentration 
it is a poison to all forms of living matter. According to Sollmann,4 Quinine 
will kill a nerve if applied directly to i t ; according to Robert,26 it kills what­
ever it reaches—nerve, skin, etc.
(4) Ulceration.—If the necrosed area reaches skin the eschar must 
necessarily be thrown off, and leave an ulcer. In intramuscular injections, 
the necrosed area does not reach skin, so no ulceration results; the necrosed 
area is ultimately converted into a fibrous nodule in the muscle. I f  the needle 
during injection is kept parallel to the skin surface, ulceration will infallibly 
occur; for the Quinine by diffusion reaches the surface and includes the 
skin in the necrosed area.
(5) Tetanus.—The occurrence of tetanus as a not infrequent sequel to 
Quinine injections has long been recognised; but a definite explanation of 
this phenomenon has not yet been given. The convulsions which occur in 
Quinine poisoning are recognised as distinctly epileptiform, and not tetanic ;39 
so the opinion of some that the tetanic symptoms are simply a manifestation of 
Quinine poisoning may be dismissed at once as untenable. But even with 
reference to true tetanus there are two ideas regarding the mode of infection. 
The more generally accepted one is that tetanus spores are introduced during or 
after the injection of Quinine; the other is that tetanus spores are already 
existent in a latent condition in the body and that they are stirred into activity 
by the trauma or the Quinine at the time of injection. In support of the latter 
idea, Tarozzi40 has shown that tetanus spores can live for over three months in 
the liver or kidney in a latent condition, but are gradually destroyed ; and by 
an artificial trauma he was able to induce these spores to germinate and produce 
“  spontaneous tetanus.”  Regarding infection during or after injection several 
points have to be considered. I f  pure tetanus cultures are introduced into the 
blood or organs of the body, the spores are soon destroyed unless conditions 
favouring their multiplication are present :41 the bacilli and spores by themselves 
in the tissues form relatively bland foreign bodies, and are slowly taken up by the
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leucocytes, possibly hours or, as stated by Tarozzi, months after injection.. 
Factors which favour multiplication of tetanus bacilli in the body, according to 
Vaillard,42 are— (1) much dirt introduced into the wound, (2) all means that keep 
leucocytes away from the inoculated spot, (3) means which afford mechanical 
protection to the bacilli, (4) the addition of certain chemicals, e.g., lactic acid,
(5) severe mechanical lesions, e.g., fracture and contusion, and (6) the introduc­
tion of certain saprophytes. As regards tetanus following Quinine injections; 
the first and fifth of these factors may be dismissed at once, and probably also 
the sixth, as tetanus has occurred even after scrupulous care in sterilising the 
injection— quite sufficient to destroy all saprophytes—had been taken. That 
Quinine can keep leucocytes away from the inoculated spot is well recognised 
(Binz) :u and this action of Quinine is accentuated in two other ways— (1) 
Quinine causes impairment of phagocytosis (Golgi),43 and (2) diminishes the 
number of leucocytes in the body, ’3 gramme of Quinine sulphate being capable 
of reducing the number of leucocytes by 7 per cent, in six hours (Marshall,5 
Sollmann4) . The coagulum at the seat of injection may possibly afford some 
mechanical protection to tetanus spores, but it can also favour their development 
in another way—phagocytes may be diverted from the relatively bland spores- 
to the more irritating coagulum. Heddmus41 has reported the occurrence of 
tetanus after the subcutaneous injection of gelatine, where probably the same 
causes, mechanical protection and diversion of leucocytes, were at work. 
Quinine is generally included with lactic acid among the chemical agents that 
favour tetanus. A probable explanation of its action is suggested by my serum 
compatibility experiments. In the coagulum formed by adding Quinine solu­
tions to ox blood-serum, Quinine was precipitated in an apparently oxidised 
form in combination with proteids (cf. Rossbacli’s33 experiments on the com­
pound formed by the combination of Quinine and albumen, and Kerner’s21 
experiments with dihydroxyl-quinine formed by acting on Quinine with 
permanganate of potassium). It is possible therefore that tetanus spores in­
troduced at the time of injection may be included in interstices of the coagulum 
nroduced by the Quinine and in a favourable fluid medium deprived of its oxygen. 
The action of Quinine in inhibiting the oxidation of guaiacum45 in the ordinary 
blood test, in inhibiting the so-called “  acid fermentation of the blood40 ”  and in 
diminishing the synthesis of hippuric acid in the kidney perfusion47 experiments 
may be similarly explained: oxygen is used up in the Quinine albumen com­
pound, and none is available for guaiacum, for the blood or for the nourishment 
of the renal cells, respectively. Regarding sterilisation of Quinine injections, 
it should be noted that all bacilli are not equally susceptible to the action of 
Quinine : anthrax spores for instance are fairly refractory (Koch)48; tetanus- 




Intramuscular injections in no way differ essentially from subcutaneous. 
Possibly absorption is slightly more energetic owing to a more active blood 
and lymph circulation and less pain is occasioned, but the same destructive 
and necrotic changes occur as in the subcutaneous proper. Kleine22 reports that 
the tissues after subcutaneous injection, especially if intramuscular, look 
severely damaged for a long time after injection ; and Mariani13 made the same 
observations in his rabbit experiments (intramuscular injections). These inju­
rious effects are hidden from view : necrosis does not reach the skin, so no ulcera­
tion follows. Paralysis, however, whether from thrombosis of blood vessels or 
from direct destruction of nerve fibres, is more liable to occur after 
intramuscular injections.
Quinine solutions so dilute as 1 in 150 and containing sufficient Quinine 
to be of any therapeutic value could not possibly be injected intramuscularly. 
Such solutions would therefore have to be injected into the subcutaneous 
connective tissue, as a Quinine infusion. The rapid and thorough absorption 
that would follow such a Quinine infusion is more than counterbalanced by 
the large ulcer that would infallibly result. Purther, we have in the intra­
venous injection of Quinine a method which will give still greater Quinine 
concentration in the blood without any of the special dangers of Quinine 
infusions.
Intravenous Injections of Quinine.
The intravenous method of administering Quinine was introduced by 
Bacelli,49 who used a solution containing Quinine hydrochloride, 1 ; sodium 
■chloride, '075 ; distilled water, 10 parts. This solution, however, the strength of 
which is about 1 in 10, did not find favour, and certainly the serum compati­
bility experiments would lead one to expect the introduction of this concen­
trated solution intravenously to be attended with grave danger. The addition 
of sodium chloride does not increase the compatibihty of Quinir.e hydrochloride 
with ox blood-serum.
I f a Quinine salt is to be safely introduced intravenously, it must be in a 
dilution of 1 in 150 at least. Preferably the Quinine salt {e.g. about seven 
grains of Quinine bi-hydrochloride) should be dissolved in two or three pints 
of normal saline. In this dilution there is no danger of thrombosis or preci­
pitation : the toxins in the blood are also diluted and their elimination favoured 
—this mode of administration being specially indicated in malignant types of 
malaria. Such solutions have been infused intravenously with good effect in 
cases of pernicious malaria. I f there is any tendency to hgemoglobinuria, I
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should recommend the substitution of Quinine alkaloid for Quinine bi-hydro­
chloride ; as the alkaloid delays haemolysis, while the acid salts of Quinine are 
strong hsemolytic agents.60
By this method of administration the special dangers of the subcutaneous 
injection of Quinine are avoided. There is no danger of necrosis, paralysis  ̂
ulceration or thrombosis. It is also very doubtful if the introduction of 
•tetanus spores with the intravenous Quinine infusion, in a bulk of two or three 
joints, would produce any harm. Pure tetanus cultures introduced into the 
blood are soon destroyed unless conditions favouring their multiplication are 
present.41 Of the five factors already mentioned which would favour their 
multiplication, only one—the presence of the chemical agent Quinine itself— 
would be operative in intravenous infusion ; and the Quinine would probably 
be in too great dilution to favour the development of tetanus bacilli.
The average amounts of Quinine eliminated in the urine after intravenous 
injection are, according to Mariani,13 20,5f per cent, on the first day, 633 per 
cent, on the second and 1*07 on the third. These results lead one to suppose that 
the therapeutic action of the intravenous administration of Quinine is not so 
fleeting as one might expect.
While investigating the hsemolytic action of Quinine and its salts I 
•devised a method of injecting Quinine alkaloid intravenously by dissolving it 
in 33per cent, alcohol (in saline), the strength of the injection fluid being about 
1 in 135.B0 As one grain of Quinine alkaloid thus requires a bulk of about 
■eight cubic centimetres, this mode of injecting Quinine is not likely to he of use 
clinically; so only a short description is required.
Birst of all, the strength of alcohol which can safely be added to blood 
serum was determined : it was found that 33per cent, alcohol is miscible with ox 
blood-serum provided that in the final mixture not more than 10 per cent, alcohol 
is present. In the next place the solubility of Quinine alkaloid in 33 per cent. 
alcohol was estimated : it was found that ’2 gramme Quinine alkaloid is solu­
ble in 2-7 cubic centimetres of 33 per cent, alcohol, i.e., about 1 in 135. It will 
he noted that this solution is more concentrated than solutions of soluble 
Quinine salts which can be used with safety for intravenous injection. Lastly 
the miscibility of this Quinine alcoholic solution with ox blood-serum was 
studied: it was found that half a cubic centimetre of Quinine alcoholic solution 
is miscible with two cubic centimetres of ox serum. It seemed probable there­
fore that this Quinine alcoholic solution could be injected intravenously 
without any change occurring in the blood, provided the quantity injected 
met with four times its own bulk of blood. These limits of safety were based 
•on the changes which occurred in vitro after standing twenty-four hours, and 
not on any changes that occurred immediatly on mixing the proposed injection
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with serum ; so that the figures given are well within the actual limits of 
safety.
Quinine alkaloid in doses up to ‘03 gramme per kilogramme of animal 
weight, dissolved in 33 per cent, alcohol (in normal saline) was injected intra­
venously in rabbits without any ill-effects being observed to follow. A  dose 
of ‘03 gramme per kilogramme of animal weight would correspond to a 
dose of 2T grammes (32-| grains) of Quinine alkaloid to man. The injec­
tions, moreover, were not made slowly hut as quickly as with any other 
solution. Quinine alkaloid is no doubt precipitated as it enters the vein, but 
it is in such a fine state of sub-division that, even if it could reach capillaries 
before being re-dissolved in the blood-serum, it could cause no obstruction.
In passing, it may be noted that, by first dissolving Quinine alkaloid in 
a minute amount of absolute alcohol and then adding normal saline to make a 
dilution of 1 of Quinine alkaloid in 2,000 or 5,000, a rapid and easy solution 
of the alkaloid is obtained for intravenous infusion. To dissolve Quinine 
alkaloid directly in water or saline is a very slow and laborious process.
Rectal Administration of Quinine.
Quinine enemata.— Quinine enemata are probably used as often for 
amoebic dysentery as for malaria. In the former case, absorption is not 
desired; in the latter, absorption is our object. The chief drawback to Quinine 
rectal injections is that Quinine salts, and particularly the more saluble salts, 
are so irritating to the mucous membrane that they are generally quickly 
returned. Prolonged retention is necessary for the efficient action of these 
injections whether they be given for amoebic dysentery or for malaria. In 
order to get sufficiently long retention, it is always necessary to add opium, 
belladonna or cocaine to the injections. Yet these substances, although they 
prolong retention, are apt to retard absorption. It is necessary, of course, before 
giving a Quinine enema to clear out the bowels with a simple enema. 
According to the National Dispensatory,10 an enema of Quinine hydrochloride 
in the same dose as by the mouth has nearly the same therapeutic effect as when 
given by the mouth, provided the Quinine salt in the enema is given in watery 
solution. This view of Quinine enemata appears to be too optimistic. Kleine12,22 
after giving an enema consisting of two grammes of Quinine hydrochloride in 
100 cubic centimetres of water found the average Quinine elimination in the 
urine to be 17'5 per cent., maximum elimination occurring between the 
fourth and tenth hours. He concluded that elimination and probably absorp­
tion from an enema containing a soluble Quinine salt are considerably smaller 
than those which take place when Quinine is given by the mouth; and 
that with a Quinine preparation which is not easily soluble absorption must be-
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much smaller still, for peristalsis is poor and the Quinine is merely in sus­
pension. These results have been confirmed by Elamini33 -who, after an enema 
containing two grammes of Quinine tannate, found 2'65 per cent, only elimi­
nated in the first 24 hours ; and also by Giemsa and Schaumann 6 who after 
giying an enema containing one gramme of Quinine alkaloid with mucilage 
of acacia and tincture of opium found only 5-177 per cent, eliminated in the 
urine in the first 24 hours. Erom these results Giemsa and Schaumann infer 
that Quinine enemata are little suited for the treatment of malaria, because— 
even if sufficiently long retained—Quinine absorption is quite insufficient, 
and particularly so if Quinine salts which are not easily soluble are employed.
As carbonic acid and bile appear to play such a prominent part in the 
absorption of Quinine from the small intestine, it is possible that the addition 
of these to enemata would help absorption. Kerner51 seems to have obtained 
quite good results Avitli carbonic acid, the salt used being Quinine hydrochloride. 
The amount of Quinine he found eliminated in the urine is given in the 
accompanying table, which is self-explanatory.
Table IX.
Elimination of Quinine in Urine after Quinine Enemata.
H ouks.
Quinine hydrochloride.
Ï 12 î 1 3 6 12 24 36 48
1 per cent, solution in 150 o.c. of 
water.
... 1 4 9 16 16 14 9 2 ...
1 per cent, solution in 150 c.c. car­
bonated water; and 100 c.c. more 




10 19 28 16 5 4
Eurther investigations regarding Quinine enemata are necessary. So far as 
•our present knowledge takes us, the best results are obtained by using Quinine 
hydrochloride in a dilution of about 1 in 50 of Avater with tincture of opium or 
belladonna or cocaine added, and injected as high as possible. Even under the 
most favourable circumstances, when retention has been sufficiently long, we 
cannot expect as much from Quinine enemata as from Quinine by the mouth.
Quinine suppositories.—These are very irritating and useless in the treat­
ment of malaria. Binz11 states that, with the rectum previously washed out 
and the suppository passed high up with the finger, retention beyond one 
hour is very exceptional.
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SUMMARY OF CHIEF RESULTS AND CONCLUSIONS. 
Solutions of Quinine Salts and Moulds.
Tlie sulphate is not the only salt of Quinine that is liable to infection with 
moulds, and the moulds which infect solutions of Quinine salts are not limited 
to the genus Pénicillium. Quinine is not so inimical to the higher fungi as to 
the lower yeast forms.
Miscibility of Quinine Salts with Ox BIood=serum,
The salts of Quinine most soluble in water, even in a dilution of 1 in 
100 are not miscible with ox blood-serum. The three salts, Quinine bi­
hydrochloride, Quinine bi-hydrobromide and Quinine urea, most frequently 
used for subcutaneous injection and in the dilution most frequently employed, 
mixed with an equal volume of ox blood-serum, in a few minutes at 17°0. 
result in the formation of a solid gelatinous mass. Quinine bi-liydrobromide 
even in a dilution of 1 in 20 produces a mass of curdy consistence. Quinine 
salts in the dilutions usually employed are quite unsuited for hypodermic use. 
The deposit which forms in vitro on adding a concentrated solution of 
Quinine salt- to blood-serum seems to contain Quinine in altered form, oxidised 
and combined with proteid. Mixing equal volumes of blood-serum and 
Quinine hydrochloride 1 in 20, it is found that slightly over half the Quinine 
is in solution and slightly under half is contained in the deposit. The greater 
the dilution of Quinine salt, the less the deposit that forms on mixing with 
blood-serum ; and therefore presumably the greater the amount of Quinine 
that remains in solution.
Solubility of Quinine Alkaloid in Ox BIood=serum and in Ox Bile.
Quinine alkaloid is soluble I in 625 of ox blood-serum, i.e., nearly three 
times as soluble in ox blood-serum as in ordinary water.
Quinine alkaloid is soluble 1 in 183 of ox bile, i.e., about nine times as 
* soluble in ox bile as in ordinary water.
Absorption of Quinine.
Too much reliance must not be placed on the amount of Quinine elimina­
tion in the urine as a gauge of the amount of Quinine absorbed, especially 
when different modes of Quinine administration are being compared. Lethality 
varies directly with thoroughness of absorption and is a reliable measure of the 
amount of absorption when comparing different modes of Quinine administra­
tion.
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Oral Administration.— Under ordinary circumstances, most of the Quinine■ 
administered by the moutli is absorbed from the small intestine ; a small amount 
possibly from the stomach, especially if administered while fasting and in the 
form of a salt easily soluble in water ; and also a relatively small amount from 
the large intestine.
Affections of the gastro-intestinal tract and liver have a marked influence 
on the amount of Quinine absorbed, as have also the food contents of the gastro­
intestinal tract and the degree of solubility of the Quinine salt employed. 
Absorption is retarded if Quinine is given with or soon after food and also if  the. 
less soluble preparations of Quinine are administered. Rapid and energetic 
absorption is best obtained by giving a soluble Quinine salt during fasting : 
gradual and prolonged absorption is attained by giving one of the less soluble 
salts of Quinine with or soon after meals, absorption under such conditions . 
being maintained at a considerable level for some eight hours. Hence, where 
sporulation is regular, a soluble Quinine salt should be given, during fasting, 
two or three hours before a paroxysm ; in other cases, one of the less soluble 
preparations of Quinine, wjth or soon after meals, every eight hours. Carbonic 
acid, like bile, probably plays an important part in the process of Quinine 
absorption.
The administration of soluble Quinine salts in capsules is bad : gastric 
irritation and trouble may follow. Where Quinine causes gastric irritation, the ; 
least soluble salts of Quinine, e.g., tannate, should be given.
Large doses., e.g., 15 grains three times daily, give better therapeutic results 
than fractional doses, e.g., four grains every two hours day and night. In 
cases where Quinine by the mouth does not produce the desired effect, attention 
should he directed to the condition of the gastro-intestinal tract and liver.
Subcutaneous (including intramuscular) administration.— Quinine salt 
solutions in the concentration usually employed for hypodermic injection, when 
mixed with blood-serum produce a coagulum which contains Quinine in altered 
form.
Quinine is precipitated at the seat of injection and over 66 per cent, of 
the amount injected intramuscularly has been recovered 17 hours afterwards 
from the muscles at the site of injection.
The amount of Quinine eliminated in the urine after this mode of ad­
ministration varies between wide limits.
Urethane, antipyrine and sodium chloride, although they increase the 
solubility of Quinine hydrochloride in water, do not increase the miscihility of 
that Quinine salt with ox blood-serum ; and the new compounds formed in 
such solutions are of doubtful therapeutic value.
H
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As regards guinea-pigs, the lethality (and therefore absorbability) of 
'Quinine by the several modes of administration is in the following order, be­
ginning with the most lethal mode of administration : (1) subcutaneous injec­
tion in extreme dilution (1 in 150), (2) oral administration during fasting, (3) 
oral administration with or immediately after food, and (4) subcutaneous 
injection in the strengths generally used for hypodermic injection (1 in 2 and 
1 in 8). The oral administration of Quinine also affords more prompt thera- 
peutic action of the alkaloid than does the subcutaneous, the subcutaneous injec­
tion of Quinine in extreme dilution (1 in 150) being excluded for clinical 
reasons. Further, subcutaneous injections are followed by various compli­
cations and mutilation. Intramuscular injections are attended by the same 
drawbacks as subcutaneous proper ; and although ulceration rarely occurs, they 
are more liable than the latter to be followed by thrombosis and paralysis.
The harmony between the results of various observations on man and 
those of my experiments on guinea-pigs justify the inference of general applic­
ability—that subcutaneous and intramuscular Quinine injections, in solutions 
o f the usual strength (1 in 1 to 1 in 10) are inferior to Quinine by the mouth 
in rapidity o f action and thoroughness o f  absorption, and that they are liable to 
be attended by grave complications, mutilation and dangers. Quinine and 
its salts are, moreover, fundamentally unsuited for hypodermic use. This mode 
o f  Quinine administration should therefore be abandoned.
Intravenous injections o f Quinine.— Great dilution (at least 1 in 150) is 
necessary in order to avoid the dangers special to Quinine. The Quinine, e.g., 
seven grains of Quinine bi-hydrochloride, should be dissolved in two or three 
pints of saline. This mode of administration is called for in cases of 
emergency, e.g., pernicious malaria with coma or other cerebral symptoms ; 
and in such cases this extreme dilution affords the additional advantage of 
attenuating the toxins and favouring their elimination. In this dilution 
intravenous injections of Quinine are quick and sure ; and, judging from the 
subsequent Quinine elimination in the urine, their action is not fleeting : 
they are attended by no risks peculiar to Quinine, but merely by those attend­
ant on intravenous iii fusions generally.
Quinine alkaloid itself, instead of one of its salts, should be used where 
there is any tendency to or fear of hæmoglobinuria : the alkaloid delays 
haemolysis, its acid salts are powerful hæmolytic agents. A solution of the 
alkaloid can be obtained rapidly and easily for intravenous infusion by first 
dissolving the alkaloid in a minute amount of absolute alcohol and then 
adding normal saline to make a solution of 1 in 2,000 or 5,000.
Intravenous injections of Quinine alkaloid dissolved in 33 per cent. 
alcohol (in saline) in a strength of about 1 in 135, have been made quickly
and safely in rabbits, and without any subsequent ill-effects—the amount of 
Quinine in the injections being equivalent to doses of 32|- grains Quinine 
alkaloid to man.
Rectal administration.—'Quinine enemeta are very irritating and are 
generally quickly returned ; they are of little therapeutic value in malaria, as 
comparatively little Quinine is absorbed even when retained sufficiently long. 
The addition of bile or carbonic acid might increase their therapeutic action. 
Salts of Quinine which are not easily soluble in water should be avoided. 
Hitherto, the best results have been obtained from Quinine hydrochloride in 
water (1 in 50) with tincture of opium or belladonna or cocaine, injected 
high up in the bowel, which has been previously washed out with a simple 
enema. Even under the most favourable circumstances, with sufficiently long 
retention, we cannot expect as much from Quinine enemeta as from Quinine 
by the mouth.
Quinine suppositories are irritating and useless in the treatment of 
malaria.
The experimental work included in this article was carried out partly 
in the Pharmacological Laboratory of the University of Edinburgh and 
partly in the Pasteur Institute of India at Kasauli ; and to Professor Sir 
Thomas P. Eraser and Captain W . E. Harvey, I.M.S., respectively, I tender 
my thanks for permission so freely granted to work in their laboratories.
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